Timeliness and actionable intelligence over I-Banks research which remains only geared to institutional investors and legacy processes. News carries with it a promise of transparency, a light that can be shined into previously dark corners.
But they don’t define any relevance to the actual value of a release - mostly due to SEC forward looking parameters. However, this news portal has been expanded to … supplement, measure and price the event and relevance to a company’s ... valuation.
July 3, 2023
Happy 4th of July and week
June 21, 2023
RegMed Investors (RMi) Research Note: Editas Medicine (EDIT) prices a $125 M offering of 12.5 M shares at $10.00
June 21, 2023
RegMed Investors (RMi) Research Note: UniQure NV (QURE -$8.08 or -41.72% to $11.33) crashed
May 27, 2023
RegMed Investors (RMi) Research Note: Q1/23 earnings reporting dates, net losses, cash positions and runway outcomes
May 15, 2023
UniQure NV (QURE) to sell royalty interest in blood disorder therapy for up to $400 M
April 10, 2023
RegMed Investors (RMi) Research Note: Q4 and FY22 earnings reporting
March 17, 2023
RegMed Investors (RMi) Research Note: Silicon Valley Bank Group (SIVB) files for bankruptcy
March 13, 2023
RegMed investors (RMi) Research Note: the aftermarket of catching a falling knife without a cut or slash
March 12, 2023
RegMed Investors: Special from Gleneagles, a luxury golf resort in Scotland, and spoke from a room framed by dark cabinets.
February 28, 2023
RegMed Investors (RMi) Research Note: Upcoming Q4 earnings reporting dates
February 8, 2023
Cellectis SA (CLLS) closes 9.9 M ADS offering at $2.50
January 25, 2023
Precigen (PGEN) $75 M offering priced at $1.75
January 24, 2023
Verastem Oncology (VSTM) $60 M Private Placement Offering of Series B Convertible Preferred Stock
January 18, 2023
bluebird bio (BLUE) prices offering of 20 M shares at $6.00
January 9, 2023
RegMed Investors (RMi) Research Note: News related to JPM23
January 2, 2023
RegMed investors (RMi) Research Note: Agenus (AGEN) possible offering of 1.95 million share
December 1, 2022
RegMed investors (RMi) Research Note: Intellia Therapeutics (NTLA) prices offering of 6.25 million shares priced at $45.80
November 15, 2022
RegMed Investors (RMi) Research Note: Applied Genetic Technologies (AGTC)
November 7, 2022
Verve Therapeutics (VERV -$8.02 or -19.08% to $23.27) crashes after FDA halts IND to test gene editor Ion patients
November 2, 2022
Compass Therapeutics (CMPX) files for a private investment in public equity (PIPE) financing to raise $80 million
October 28, 2022
RegMed Investors (RMi): Research Note: Solid Biosciences (SLDB) announces a 1-for-15 Reverse Stock Split
October 25, 2022
Syncona (SYNC) to acquire Applied Genetic Technologies Corporation (AGTC) update
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors